{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:43:12Z","timestamp":1778186592174,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Atrial fibrillation (AF) imposes an inherent risk for stroke and silent cerebral emboli, partly related to left atrial (LA) remodeling and activation of inflammatory and coagulation systems. The aim was to explore the effects of cardioversion (CV) and short-lasting AF on left atrial hemodynamics, inflammatory, coagulative and cardiac biomarkers, and the association between LA functional recovery and the presence of a prior history of AF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients referred for CV within 48 h after AF onset were prospectively included. Echocardiography and blood sampling were performed immediately prior, 1\u20133 h after, and at 7\u201310 days after CV. The presence of chronic white matter hyperintensities (WMH) on magnetic resonance imaging was related to biomarker levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-three patients (84% males), aged 55\u00b19.6 years, with median CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score 1 (IQR 0\u20131) were included. The LA emptying fraction (LAEF), LA peak longitudinal strain during reservoir, conduit, and contractile phases improved significantly after CV. Only LAEF normalized within 10 days. Interleukin-6, high-sensitivity cardiac-troponin-T (hs-cTNT), N-terminal-pro-brain-natriuretic peptide, prothrombin-fragment 1+2 (PTf1+2), and fibrinogen decreased significantly after CV. There was a trend towards higher C-reactive protein, hs-cTNT, and PTf1+2 levels in patients with WMH (<jats:italic>n<\/jats:italic>=21) compared to those without (<jats:italic>n<\/jats:italic>=22). At 7\u201310 days, the LAEF was significantly lower in patients with a prior history of AF versus those without.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although LA stunning resolved within 10 days, LAEF remained significantly lower in patients with a prior history of AF versus those without. Inflammatory and coagulative biomarkers were higher before CV, but subsided after 7\u201310 days, which altogether might suggest an enhanced thrombogenicity, even in these low-risk patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10840-021-01078-9","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T02:02:38Z","timestamp":1635040958000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent-onset atrial fibrillation: a study exploring the elements of Virchow\u2019s triad after cardioversion"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-7446","authenticated-orcid":false,"given":"Panagiotis","family":"Arvanitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Karin","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Malmborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Gerovasileiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elna-Marie","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Blomstr\u00f6m-Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,24]]},"reference":[{"key":"1078_CR1","unstructured":"Virchow R. Thrombosis and Emboli:(1846-1856). Canton: Science History Publ. 1998, vi p234."},{"issue":"19","key":"1078_CR2","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","volume":"106","author":"WY Ding","year":"2020","unstructured":"Ding WY, Gupta D, Lip GYH. Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020 (in eng). Heart. 2020;106(19):1463\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2020-316977.","journal-title":"Heart"},{"issue":"9","key":"1078_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes, (in eng). Circ Res. 2017;120(9):1501\u201317. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309732.","journal-title":"Circ Res"},{"issue":"2-3","key":"1078_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0167-5273(03)00107-4","volume":"92","author":"IA Khan","year":"2003","unstructured":"Khan IA. Atrial stunning: basics and clinical considerations, (in eng). Int J Cardiol. 2003;92(2-3):113\u201328. https:\/\/doi.org\/10.1016\/s0167-5273(03)00107-4.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1078_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcmg.2016.11.003","volume":"10","author":"L Thomas","year":"2017","unstructured":"Thomas L, Abhayaratna WP. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance, (in eng). JACC Cardiovasc Imaging. 2017;10(1):65\u201377. https:\/\/doi.org\/10.1016\/j.jcmg.2016.11.003.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1078_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0008-6363(01)00367-4","volume":"52","author":"VLJL Thijssen","year":"2001","unstructured":"Thijssen VLJL, Ausma J, Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovascular Res. 2001;52(1):14\u201324. https:\/\/doi.org\/10.1016\/s0008-6363(01)00367-4.","journal-title":"Cardiovascular Res"},{"issue":"20","key":"1078_CR7","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","volume":"124","author":"YK Iwasaki","year":"2011","unstructured":"Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management, (in eng). Circulation. 2011;124(20):2264\u201374. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.019893.","journal-title":"Circulation"},{"issue":"12","key":"1078_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0002-9149(98)00704-8","volume":"82","author":"M Berger","year":"1998","unstructured":"Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis, (in eng). Am J Cardiol. 1998;82(12):1545\u20137, A8.","journal-title":"Am J Cardiol"},{"issue":"9506","key":"1078_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(06)68037-9","volume":"367","author":"S Nattel","year":"2006","unstructured":"Nattel S, Opie LH. Controversies in atrial fibrillation, (in eng). Lancet. 2006;367(9506):262\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(06)68037-9.","journal-title":"Lancet"},{"issue":"13","key":"1078_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","volume":"62","author":"KE Airaksinen","year":"2013","unstructured":"Airaksinen KE, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study, (in eng). J Am Coll Cardiol. 2013;62(13):1187\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.089.","journal-title":"J Am Coll Cardiol"},{"issue":"9658","key":"1078_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","volume":"373","author":"T Watson","year":"2009","unstructured":"Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited, (in eng). Lancet. 2009;373(9658):155\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(09)60040-4.","journal-title":"Lancet"},{"issue":"2","key":"1078_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.recesp.2011.08.017","volume":"65","author":"M V\u00e1zquez","year":"2012","unstructured":"V\u00e1zquez M, et al. Assessment of silent microembolism by magnetic resonance imaging after cardioversion in atrial fibrillation, in eng|spa. Rev Esp Cardiol (Engl Ed). 2012;65(2):139\u201342. https:\/\/doi.org\/10.1016\/j.recesp.2011.08.017.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijcha.2018.04.006","volume":"19","author":"F Moroni","year":"2018","unstructured":"Moroni F, Ammirati E, Rocca MA, Filippi M, Magnoni M, Camici PG. Cardiovascular disease and brain health: focus on white matter hyperintensities, (in eng). Int J Cardiol Heart Vasc. 2018;19:63\u20139. https:\/\/doi.org\/10.1016\/j.ijcha.2018.04.006.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"1078_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.09.004","volume":"21","author":"A Kobayashi","year":"2012","unstructured":"Kobayashi A, Iguchi M, Shimizu S, Uchiyama S. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation, (in eng). J Stroke Cerebrovasc Dis. 2012;21(4):310\u20137. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2010.09.004.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1078_CR15","doi-asserted-by":"crossref","unstructured":"P. Arvanitis et al. Serial magnetic resonance imaging after electrical cardioversion of recent onset atrial fibrillation in anticoagulant-na\u00efve patients \u2013 a prospective study exploring clinically silent cerebral lesions. J Atr Fibrillation. 2020;13 2.","DOI":"10.4022\/jafib.2271"},{"issue":"3","key":"1078_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, (in eng). Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201370. https:\/\/doi.org\/10.1093\/ehjci\/jev014.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"1078_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging, (in eng). Eur Heart J Cardiovasc Imaging. 2018;19(6):591\u2013600. https:\/\/doi.org\/10.1093\/ehjci\/jey042.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"1078_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging, (in eng). AJR Am J Roentgenol. 1987;149(2):351\u20136. https:\/\/doi.org\/10.2214\/ajr.149.2.351.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1078_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials \u2013 a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162. https:\/\/doi.org\/10.1186\/s12874-017-0442-1.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1078_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, (in eng). Chest. 2010;137(2):263\u201372. https:\/\/doi.org\/10.1378\/chest.09-1584.","journal-title":"Chest"},{"issue":"3","key":"1078_CR21","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.4022\/jafib.2148","volume":"12","author":"A Lenart-Migdalska","year":"2019","unstructured":"Lenart-Migdalska A, et al. Assessment of left atrial function in patients with paroxysmal, persistent, and permanent atrial fibrillation using two-dimensional strain, (in eng). J Atr Fibrillation. 2019;12(3):2148. https:\/\/doi.org\/10.4022\/jafib.2148.","journal-title":"J Atr Fibrillation"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijcard.2019.04.091","volume":"292","author":"E Akkaya","year":"2019","unstructured":"Akkaya E, et al. Clinical outcome and left atrial function after left atrial roof ablation using the cryoballoon technique in patients with symptomatic persistent atrial fibrillation, (in eng). Int J Cardiol. 2019;292:112\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.091.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1078_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10554-018-1470-6","volume":"35","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. Assessment of left atrial remodeling in paroxysmal atrial fibrillation with speckle tracking echocardiography: a study with an electrophysiological mapping system, (in eng). Int J Cardiovasc Imaging. 2019;35(3):451\u20139. https:\/\/doi.org\/10.1007\/s10554-018-1470-6.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"1078_CR24","doi-asserted-by":"publisher","first-page":"e002769","DOI":"10.1161\/CIRCIMAGING.114.002769","volume":"8","author":"M Habibi","year":"2015","unstructured":"Habibi M, et al. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study, (in eng). Circ Cardiovasc Imaging. 2015;8(2):e002769. https:\/\/doi.org\/10.1161\/CIRCIMAGING.114.002769.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"1078_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.echo.2015.01.017","volume":"28","author":"YE Yoon","year":"2015","unstructured":"Yoon YE, et al. Echocardiographic predictors of progression to persistent or permanent atrial fibrillation in patients with paroxysmal atrial fibrillation (E6P Study), (in eng). J Am Soc Echocardiogr. 2015;28(6):709\u201317. https:\/\/doi.org\/10.1016\/j.echo.2015.01.017.","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"1078_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.echo.2016.09.013","volume":"30","author":"DP Leong","year":"2017","unstructured":"Leong DP, et al. Left atrial dysfunction in the pathogenesis of cryptogenic stroke: novel insights from speckle-tracking echocardiography, (in eng). J Am Soc Echocardiogr. 2017;30(1):71\u201379.e1. https:\/\/doi.org\/10.1016\/j.echo.2016.09.013.","journal-title":"J Am Soc Echocardiogr"},{"issue":"22","key":"1078_CR27","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","volume":"60","author":"Y Guo","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation, (in eng). J Am Coll Cardiol. 2012;60(22):2263\u201370. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.063.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1078_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.amjcard.2004.11.032","volume":"95","author":"SN Psychari","year":"2005","unstructured":"Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95(6):764\u20137.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1078_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/hrt.2006.108688","volume":"94","author":"EM Kallergis","year":"2008","unstructured":"Kallergis EM, et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart. 2008;94(2):200\u20134.","journal-title":"Heart"},{"issue":"6","key":"1078_CR30","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4022\/jafib.1530","volume":"9","author":"JP Costabel","year":"2017","unstructured":"Costabel JP, Burgos LM, Trivi M. The significance of troponin elevation in atrial fibrillation, (in eng). J Atr Fibrillation. 2017;9(6):1530.","journal-title":"J Atr Fibrillation"},{"issue":"5","key":"1078_CR31","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1016\/j.ijcard.2013.07.026","volume":"168","author":"R Provid\u00eancia","year":"2013","unstructured":"Provid\u00eancia R, Paiva L, Barra S, Faustino A. Troponin rise in patients with atrial fibrillation: a marker of adverse prognosis and increased thromboembolic risk. Int J Cardiol. 2013;168(5):4889.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1078_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijcard.2014.03.113","volume":"173","author":"G Lippi","year":"2014","unstructured":"Lippi G, Picanza A, Formentini A, Bonfanti L, Cervellin G. The concentration of troponin I is increased in patients with acute-onset atrial fibrillation. Int J Cardiology. 2014;173(3):579\u201380.","journal-title":"Int J Cardiology"},{"issue":"5","key":"1078_CR33","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.hrthm.2015.01.020","volume":"12","author":"AA Hussein","year":"2015","unstructured":"Hussein AA, et al. Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults. Heart rhythm. 2015;12(5):879\u201385.","journal-title":"Heart rhythm"},{"issue":"5","key":"1078_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.amjcard.2019.12.004","volume":"125","author":"BS Kim","year":"2020","unstructured":"Kim BS, et al. Usefulness of high-sensitivity troponin i to predict outcome in patients with newly detected atrial fibrillation, (in eng). Am J Cardiol. 2020;125(5):744\u201350. https:\/\/doi.org\/10.1016\/j.amjcard.2019.12.004.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1078_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.113.006286","volume":"129","author":"Z Hijazi","year":"2014","unstructured":"Hijazi Z, et al. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014;129(6):625\u201334.","journal-title":"Circulation"},{"issue":"10S","key":"1078_CR36","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jacep.2017.09.098","volume":"3","author":"M Negreva","year":"2017","unstructured":"Negreva M, Vitlianov K, Tasheva R. 073_16773-H1 early markers of coagulation activity prothrombin fragments 1+2 and fibrinopeptide A are significantly increased in patients with paroxysmal atrial fibrillation. JACC: Clin Electrophysiol. 2017;3(10S):S23\u20133. https:\/\/doi.org\/10.1016\/j.jacep.2017.09.098.","journal-title":"JACC: Clin Electrophysiol"},{"issue":"4","key":"1078_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0002-8703(96)90278-1","volume":"131","author":"GY Lip","year":"1996","unstructured":"Lip GY, Lowe GD, Rumley A, Dunn FG. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J. 1996;131(4):724\u201330.","journal-title":"Am Heart J"},{"issue":"1","key":"1078_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/s0735-1097(96)00427-5","volume":"29","author":"H Sohara","year":"1997","unstructured":"Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation, (in eng). J Am Coll Cardiol. 1997;29(1):106\u201312. https:\/\/doi.org\/10.1016\/s0735-1097(96)00427-5.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1078_CR39","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/euhj.2000.2531","volume":"22","author":"FL Li-Saw-Hee","year":"2001","unstructured":"Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J. 2001;22(18):1741\u20137.","journal-title":"Eur Heart J"},{"issue":"9","key":"1078_CR40","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/j.1538-7836.2006.02115.x","volume":"4","author":"J Heeringa","year":"2006","unstructured":"Heeringa J, et al. A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999, (in eng). J Thromb Haemost. 2006;4(9):1944\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02115.x.","journal-title":"J Thromb Haemost"},{"issue":"33","key":"1078_CR41","doi-asserted-by":"publisher","first-page":"e11892","DOI":"10.1097\/MD.0000000000011892","volume":"97","author":"C Wei","year":"2018","unstructured":"Wei C, Zhang S, Liu J, Yuan R, Liu M. Relationship of cardiac biomarkers with white matter hyperintensities in cardioembolic stroke due to atrial fibrillation and\/or rheumatic heart disease, (in eng). Medicine (Baltimore). 2018;97(33):e11892. https:\/\/doi.org\/10.1097\/MD.0000000000011892.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1078_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00415-018-9085-3","volume":"266","author":"R von Rennenberg","year":"2019","unstructured":"von Rennenberg R, et al. High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke, (in eng). J Neurol. 2019;266(1):37\u201345. https:\/\/doi.org\/10.1007\/s00415-018-9085-3.","journal-title":"J Neurol"},{"issue":"7","key":"1078_CR43","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1161\/STROKEAHA.113.001128","volume":"44","author":"RT Dadu","year":"2013","unstructured":"Dadu RT, et al. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study, (in eng). Stroke. 2013;44(7):1803\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.113.001128.","journal-title":"Stroke"},{"issue":"10","key":"1078_CR44","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1212\/WNL.0b013e318248e50f","volume":"78","author":"CL Satizabal","year":"2012","unstructured":"Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study, (in eng). Neurology. 2012;78(10):720\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318248e50f.","journal-title":"Neurology"},{"issue":"3","key":"1078_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1447-0594.2010.00686.x","volume":"11","author":"K Nagai","year":"2011","unstructured":"Nagai K, Kozaki K, Sonohara K, Akishita M, Toba K. Relationship between interleukin-6 and cerebral deep white matter and periventricular hyperintensity in elderly women, (in eng). Geriatr Gerontol Int. 2011;11(3):328\u201332. https:\/\/doi.org\/10.1111\/j.1447-0594.2010.00686.x.","journal-title":"Geriatr Gerontol Int"},{"issue":"10","key":"1078_CR46","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ajh.2012.85","volume":"25","author":"M Nagai","year":"2012","unstructured":"Nagai M, Hoshide S, Kario K. Association of prothrombotic status with markers of cerebral small vessel disease in elderly hypertensive patients, (in eng). Am J Hypertens. 2012;25(10):1088\u201394. https:\/\/doi.org\/10.1038\/ajh.2012.85.","journal-title":"Am J Hypertens"},{"issue":"9","key":"1078_CR47","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.025","volume":"27","author":"CJ You","year":"2018","unstructured":"You CJ, Liu D, Liu LL, Liu QQ, Li GZ. Correlation between fibrinogen and white matter hyperintensities among nondiabetic individuals with noncardiogenic ischemic stroke, (in eng). J Stroke Cerebrovasc Dis. 2018;27(9):2360\u20136. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.04.025.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1078_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp-2016-315457","volume":"89","author":"Y Mayasi","year":"2018","unstructured":"Mayasi Y, et al. Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke, (in eng). J Neurol Neurosurg Psychiatry. 2018;89(1):6\u201313. https:\/\/doi.org\/10.1136\/jnnp-2016-315457.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"21","key":"1078_CR49","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2013.05.074","volume":"62","author":"F Gaita","year":"2013","unstructured":"Gaita F, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function, (in eng). J Am Coll Cardiol. 2013;62(21):1990\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.074.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-021-01078-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T06:08:52Z","timestamp":1656310132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-021-01078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1007\/s10840-021-01078-9","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,24]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Swedish Ethical Review Authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from each study participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from each study participant.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors Panagiotis Arvanitis, Anna-Karin Johansson, Mats Frick, Helena Malmborg, Spyridon Gerovasileiou, and Elna-Marie Larsson have no conflict of interest to declare that are relevant to the content of this article. Carina Blomstr\u00f6m-Lundqvist has received research grants from Medtronic and speaker honorarium from Boston Scientific, Bayer, Sanofi, Pfizer, Johnson-Johnson, and Cathprint.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}